Intravesicular Prostaglandin E 2 for the Prophylaxis of Urinary Retention after Colpohysterectomy

Abstract

The aim of this study was to assess the efficacy of PGE₂ in enhancing bladder function after vaginal hysterectomy. A total of 110 women with or without urinary incontinence underwent vaginal hysterectomy and cystourethropexy surgery because of grade II or III genital prolapse. Preoperatively the patients were randomly assigned to two groups: group 1 (n = 50) received on the fourth post-operative day, before removal of the bladder catheter, an intravesicular solution of 1.50 mg PGE₂ (2 × 0.75 mg); group 2 (n = 60) did not receive any prophylaxis for urinary retention. In the PGE₂-treated group significantly fewer patients had urinary retention for 3 days or more (10%, P < 0.05) than in the control group (27%). The use of intravesicular PGE₂ reduced the time taken to restore detrusor function.

Keywords

Prostaglandins Vaginal hysterectomy Genital prolapse Urinary retention Detrusor function

Get full access to this article

View all access options for this article.

References

Grignaffini

Petrelli

Bazzani

: Ritenzione urinaria post-chirurgica. Gli specializzati oggi: Ginecologia 1984; 3: 11–15.

Bultitude

Hills

Shuttliworth

KED

: Clinical and experimental studies on the action of prostaglandins and their synthesis inhibitors on detrusor muscle in vitro and in vivo. Br J Urol 1976; 48: 631–637.

Klarskov

Gerstenberg

Ramirez

: Prostaglandin type E activity dominates in urinary tract smooth muscle in vitro . J Urol 1983; 129: 1071–1074.

Desmond

Bultitude

Hills

: Clinical experience with intravesical prostaglandin E2: a prospective study of 36 patients. Br J Urol 1980; 52: 357–366.